All Type of News
“The revitalization of the diet pill market is expected due to launches of new drugs”… Medical doctors crowded at the conference
600 medical doctors participated in the ‘Korea Obesity Research Committee Academic Conference’ held at 9 AM on the 2nd.
As diet pills has newly been approve by the FDA in the states and are expected to be sold in the...
Zuellig Pharma stated “We will make sure to minimize on collecting personal information”
When it comes to the ‘Agreement to Collect Personal Information’, Zuellig Pharma notified to Yakup New “Zuellig Pharma Korea is following the Personal Information Protection Law and making efforts to minimize on colle...
Pfizer Korea stated “We need some time to review the distribution cost raise”
It was told that Pfizer Korea, which is confronting a faceoff against the pharmaceutical distribution industry over distribution cost, announced its positive opinion for the distribution cost raise.
According to the ...
Daewoong Pharmaceutical issued company stocks worth of KRW 100 billion
Daewoong Pharmaceutical announced on the 30th that the company completed issuing non-guaranteed bonds worth of KRW 100 billion to construct a factory in Osong, Chungcheongbuk-do, Korea.
The newly issued company stock...
An increasing curve of new hypertriglyceridemia drugs
New hypertriglyceridemia drugs are drawing attention in the pharmaceutical market.
Hypertriglyceridemia is one of the dyslipidemias, which is more common than hypercholesteremia and which must requires appropriate me...
Domestic pharmaceutical companies are keeping eyes on gigantic hepatitis B drugs to catch the right moment
Domestic pharmaceutical companies in Korea have concentrated on launches of follow-up drugs for Baraclude(BMS) and Viread(Gilead), which divide the hepatitis B drug market into two parts.
Baraclude is in the state wh...
Direct dealings of pharmaceutical companies with pharmacies disturb invigoration of OTC drugs
Although the entire pharmaceutical industry, such as manufacturing, wholesale and pharmacies, is actively working on invigoration of OTC (Over The Counter) drugs, it has not had any accomplishment, yet.
The pharmaceu...
The beginning of conflict between the pharmaceutical industry and Pfizer KoreaThe conflict between the pharmaceutical distribution industry and Pfizer Korea over distribution cost has begun.
The pharmaceutical distribution industry, after the accomplishm...
|
Pharmaceutical companies are moving forward to raise funds… Handok’s purpose is ‘Debt Repayment’There have been continuous actions to raise funds among domestic pharmaceutical companies in Korea. While Hanmi Pharmaceutical recapitalized KRW 100 billion to secure funds for ...
|
6 pharmaceutical companies are challenging on the exclusive sale rights for Ezetimibe
While domestic pharmaceutical companies in Korea are competing for the Rosuvastatin-Ezetimibe complex, competition for patent on the complex has opened up as well.
Especially, since the exclusive sale rights will be ...
